EP 4: Frank Veith: A Professional and Personal Primer - Part 2
In part two, Steve Elias, MD continues his discussion with renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
Where does Prof Veith see the future of vascular surgery in light of developing technology and medical treatment? Listen now to the concluding episode and find out!
For more information on VEITHsymposium, program and registration details can be found at https://www.veithsymposium.org.
Hosted by @DrSteveElias. Produced by @RadcliffeVASCU.
What to listen for:
In this episode they discuss:
- [01.00] ‘Money talks’: the ethics of money and malpractice
- [02.20] ‘The heart doctors’: educating the public on vascular surgery and disease
- [09.15] ‘The next big thing’: an alternative approach to the talks at congress
- [15.13] The origins of the VEITH acronym
- [16.00] Blue-sky thinking: what would you change about VEITH?
- [20.50] The future for VEITH
- [28.00] The future of vascular surgery, medical treatments and interventions
- [34.50] Super-specialisations in vascular surgery
- [35.30] The final word from Frank Veith
Read MoreRead Less
Steve Elias, MD meets with an all-American panel: Suman Wasan, Yogendra Kanthi, Raghu Kolluri and Thom Rooke to discuss the importance of the vascular medicine specialist in treating patients with complex disease.
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
Read More
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
All Episodes
Is 2020 the death of the congress as we know it?
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Read More
Will a phoenix rise from the ashes and what will future congress sessions look like in the future?
Non-societal representatives, Manjit Gohel (Charing Cross), Jose Almeida (IVC), Antonio Gasparis (Venous Symposium), Nicos Labroupoulos (EVM) and Prof Frank Veith (VEITH), join the discussion today to examine the issues impacting venous meetings in 2020.
Listen to them discuss the impact that COVID-19 has had on society meeting attendance this year and what’s been learnt about hosting meetings as a result. Hear them discuss the pros and cons of virtual meeting attendance and their thoughts around the challenges of postponement and reinvigoration, as they consider what the future might hold for education in 2021/22.
Superficial vein disease is a lifestyle condition and a relatively non-harmful disease that can be treated. More prevalent in females and often linked to lifestyle choices such as smoking and obesity, it is also typically inherited through genetics, therefore it’s a disease that is difficult for physicians to prevent or control.
So, is superficial disease dead or not?
Read More
So, is superficial disease dead or not?
The treatment of venous thrombosis has historically been undertreated and under-recognised. In this episode, Steve Elias, MD meets with Makis Avgerinos (Uni of Pittsburgh, US), Mitchell Silver (Ohio Health, US), John Moriarty (UCLA, US) and Thomas Bernik (Englewood Health, NJ, US) to discuss how deep vein thrombosis (DVT) has become the latest ‘hot topic’ in vascular medicine. Together they unpick how thought processes and available technologies are changing to better treat this disease.
Read More
Steve Elias, MD meets with an all-American panel: Suman Wasan, Yogendra Kanthi, Raghu Kolluri and Thom Rooke to discuss the importance of the vascular medicine specialist in treating patients with complex disease.
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
Read More
They look at a number of issues surrounding this underrepresented area of expertise, namely the importance of the relationship between the vascular surgeon, vein specialists and vascular medicine and their broad spectrum of specialities.
In part two, Steve Elias, MD, continues his discussion with renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
Read More
They discuss a variety of issues including the ethics of money and malpractice and the importance of educating patients on vascular surgery and vascular disease. Listen to Frank’s take on the VEITH Symposium’s success, how he’d like to see it develop in the future and why he feels interventional cardiologists and radiologists are essential for VEITH’s long-term growth.
In this two-part series Steve Elias, MD talks to renowned vascular surgeon and organiser of the VEITHsymposium™, Professor Frank Veith.
Part-one sees them discuss a variety of topics in the vascular world including the origins and growth of the VEITHsymposium™ (which is now in its 47th year!), the importance of leadership, working with cardiologists and the controversial issues around procedure abuse in medicine.
Read More
Part-one sees them discuss a variety of topics in the vascular world including the origins and growth of the VEITHsymposium™ (which is now in its 47th year!), the importance of leadership, working with cardiologists and the controversial issues around procedure abuse in medicine.
How has education and training for physicians changed in light of the COVID-19 pandemic? Steve Elias, MD, meets with key industry figures from AngioDynamics, Philips, Medtronic as well as event organisers, Radcliffe Group, to gain a different perspective, this time from industry on their response to the recent pandemic.
Read More
In this episode, Steve Elias meets with a panel of expert venous physicians to discuss the immediate and future challenges that COVID-19 has caused on venous and vascular education.
Hear them relate the impact that COVID-19 has had on various interventional procedures and the effect it’s had on the organisation and timing of key educational meetings. Finally, they express their thoughts on the long-term changes on educational paradigms that the post-COVID era may bring such as live meetings, hybrid meetings, eLearning and the use of webinar-based platforms.
Read More
Hear them relate the impact that COVID-19 has had on various interventional procedures and the effect it’s had on the organisation and timing of key educational meetings. Finally, they express their thoughts on the long-term changes on educational paradigms that the post-COVID era may bring such as live meetings, hybrid meetings, eLearning and the use of webinar-based platforms.
The coordinated registry network (CRN) aims to collect and compare data from diverse registries with similar data points, to help physicians address specific questions based on collective real-world data.
Steve Elias meets with Jens Eldruip-Jorgensen (Maine, US), Marlin Schul (Indiana, US) and Nicholas Osbourne (Michigan, US) to find out more about the aims of the Coordinated Research Network and its impact on real-world practice to treat patients with venous disease. Highlights include discussions around the benefits and challenges of registry data, as well as a look at the current data coming out from the CRN and its implications for clinicians.
Submit your questions/feedback to Steve via: podcast@radcliffe-group.com. Hosted by @DrSteveElias. Produced by @RadcliffeVASCU.
Read More
Steve Elias meets with Jens Eldruip-Jorgensen (Maine, US), Marlin Schul (Indiana, US) and Nicholas Osbourne (Michigan, US) to find out more about the aims of the Coordinated Research Network and its impact on real-world practice to treat patients with venous disease. Highlights include discussions around the benefits and challenges of registry data, as well as a look at the current data coming out from the CRN and its implications for clinicians.
Submit your questions/feedback to Steve via: podcast@radcliffe-group.com. Hosted by @DrSteveElias. Produced by @RadcliffeVASCU.
To treat or not to treat, that is the question.
In this week's episode, host Dr Laura Redman considers the darker side of medicine to discuss whether venous disease is being treated for the right reasons and is joined by panellists, Prof Lowell Kabnick (Vascular Surgeon, US) and Dr Muhammed Zaki Shaik (Life Mount Edgemont Hospital, SA) who together discuss this topical issue with consideration for treating C2 varicose veins, venous ulcers and venous insufficiency.
Read More
In this week's episode, host Dr Laura Redman considers the darker side of medicine to discuss whether venous disease is being treated for the right reasons and is joined by panellists, Prof Lowell Kabnick (Vascular Surgeon, US) and Dr Muhammed Zaki Shaik (Life Mount Edgemont Hospital, SA) who together discuss this topical issue with consideration for treating C2 varicose veins, venous ulcers and venous insufficiency.
"Life is short, the art long." Hippocrates II
This month's episode hosted by veinPODCAST's new anchor, Dr Laura Redman (Vascular Surgeon, Cape Town, SA) features guests Prof Håkan Brorson (Plastic Surgeon, Malmö, Sweden) and Suzie Davey (Occupational/Lymphoedema Therapist, SA) to discuss issues surrounding primary and secondary lymphoedema in patients.
Read More
This month's episode hosted by veinPODCAST's new anchor, Dr Laura Redman (Vascular Surgeon, Cape Town, SA) features guests Prof Håkan Brorson (Plastic Surgeon, Malmö, Sweden) and Suzie Davey (Occupational/Lymphoedema Therapist, SA) to discuss issues surrounding primary and secondary lymphoedema in patients.
Are we in a current state of dystopia with regards to societal live meetings? Are these now a thing of the past?
In this month’s podcast episode, Steve Elias, MD is joined by executive directors from The American Venous Forum, The American Vein and Lymphatic Society, The Society of Vascular Surgery and The Society of Interventional Radiology, who together look at the current challenges for the future of society meetings and consider the steps they are taking to work towards a ‘new normal’.
In this session, they debate and discuss suggestions for innovation, as well as new engagement strategies, as they hope to embark on society meetings in a ‘Brave New World’.
Read More
In this month’s podcast episode, Steve Elias, MD is joined by executive directors from The American Venous Forum, The American Vein and Lymphatic Society, The Society of Vascular Surgery and The Society of Interventional Radiology, who together look at the current challenges for the future of society meetings and consider the steps they are taking to work towards a ‘new normal’.
In this session, they debate and discuss suggestions for innovation, as well as new engagement strategies, as they hope to embark on society meetings in a ‘Brave New World’.
Purgatory is defined as “a place or state of suffering” according to the Oxford dictionary.
This month’s episode is ‘the podcast with all the questions but not all of the answers’ as Steve Elias, MD, and his expert guest panel including Mark Meissner, Raghu Kolluri, Manu Aggarwal and Tom O’Donnell consider the interesting questions in the grey zones of venous disease. Hear them discuss the unknowns around techniques, technology, diagnostics, therapeutics and education in venous disease and how there is so much more to understand in this exciting field of medicine.
Read More
This month’s episode is ‘the podcast with all the questions but not all of the answers’ as Steve Elias, MD, and his expert guest panel including Mark Meissner, Raghu Kolluri, Manu Aggarwal and Tom O’Donnell consider the interesting questions in the grey zones of venous disease. Hear them discuss the unknowns around techniques, technology, diagnostics, therapeutics and education in venous disease and how there is so much more to understand in this exciting field of medicine.
Infrainguinal deep venous disease is quite common. However, most vein specialists are not aware of many new options available to help patients.
In this latest veinPODCAST episode, Steve Elias, MD, meets with an expert panel to discuss Infrainguinal Deep Venous Disease from many aspects including reflux, post-thrombotic and obstructive disease. They consider what can be done now to help patients with current knowledge and available technology and what is needed to further support treatment of this condition in the future?
Read More
In this latest veinPODCAST episode, Steve Elias, MD, meets with an expert panel to discuss Infrainguinal Deep Venous Disease from many aspects including reflux, post-thrombotic and obstructive disease. They consider what can be done now to help patients with current knowledge and available technology and what is needed to further support treatment of this condition in the future?